Scott Kellen, CPA (inactive)

Scott Kellen, CPA (inactive), has a diverse work experience spanning over two decades. Scott served as the Chief Financial Officer at DiaMedica Therapeutics Inc. from April 2018 to the present. Prior to that, they held the role of Chief Financial Officer at Sun BioPharma, Inc. for over two years, where they focused on developing therapeutics for pancreatic diseases.

From 2010 to 2015, Scott worked as the Chief Operating Officer, Chief Financial Officer, and Corporate Secretary at Kips Bay Medical, Inc., a medical device company specializing in coronary artery bypass grafting surgery. Before that, they established their own business called Finance & Management Solutions in 2009, providing financial services to start-ups and Fortune 1000 companies.

Scott also has experience as a Finance Director at Transoma Medical, Inc. from 2007 to 2009 and as a Corporate Controller at ev3 from 2005 to 2007. Scott began their career at Deloitte & Touche as a Senior Manager in Audit and Advisory Services from 2003 to 2005. Overall, Scott is a versatile and accomplished leader with expertise in multiple industries and diverse roles, including finance, accounting, and management.

Scott Kellen, CPA (inactive), obtained a Bachelor of Science in Business Administration with an Accounting Emphasis from the University of South Dakota. Scott completed their degree from 1983 to 1987. Scott also holds a CPA certification, although it is currently inactive, and the institution and year of acquisition are not available.